Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Drug guidance

Nirsevimab for prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants during their first RSV season

Condition

Infections

Respiratory

1 July 2026

-

Published on 01 Jul 2026
Last Updated on 01 Jul 2026

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has not recommended nirsevimab for inclusion on the MOH Subsidised Vaccine List (SVL) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract disease in infants during their first RSV season. The decision was based on the unfavourable cost effectiveness of nirsevimab compared with no immunisation, and the unacceptable price-volume agreement proposed by the company. 

Nirsevimab for prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants during their first RSV season (1 July 2026) [PDF, 319.91 KB]

Back to top